[go: up one dir, main page]

McKenzie et al., 1963 - Google Patents

Fibrinogen titer as an indicator of physiologic stability

McKenzie et al., 1963

Document ID
17442576763396854937
Author
McKenzie J
Celander D
Guest M
Publication year
Publication venue
American Journal of Physiology-Legacy Content

External Links

Snippet

A semimicro method was developed and used to determine the levels of fibrinogen in two groups of dogs. One group was obtained from the dog pound and their plasma fibrinogen levels were determined immediately. The other group was kept in the departmental animal …
Continue reading at journals.physiology.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Lum et al. A comparison of serum versus heparinized plasma for routine chemistry tests
Egeberg The blood coagulability in diabetic patients
Seegers et al. Fundamental interactions and effect of storage, ether, adsorbants and blood clotting on plasma antithrombin activity
Frigeni et al. Functional and molecular studies in primary carnitine deficiency
Cella et al. β‐thromboglobulin, platelet production time and platelet function in vascular disease
HELMER et al. The quantitative determination of renin in the plasma of patients with arterial hypertension
Ingram A suggested schedule for the rapid investigation of acute haemostatic failure
Kanayama et al. Cold-induced stress stimulates the sympathetic nervous system, causing hypertension and proteinuria in rats
Kyrle et al. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man-effect of low-dose aspirin
Boger et al. Vitamin B12: correlation of serum concentrations and age
McKenzie et al. Fibrinogen titer as an indicator of physiologic stability
Knight et al. FIBRINOLYTIC RESPONSE TO SURGERY LABILE AND STABLE PATTERNS AND THEIR RELEVANCE TO POST-OPERATIVE DEEP VENOUS THROMBOSIS
White et al. Plasma ionic calcium levels following injection of chloride, gluconate, and gluceptate salts of calcium
Peden Jr et al. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation
Mann et al. Effect of removal of the liver on blood coagulation
Moosa et al. Elevated platelet‐free calcium in uraemia
Paladini et al. The estimation of angiotensin in blood
McLeod et al. Studies on the inhibition of C [unk] 56 initiated lysis (reactive lysis): I. Description of the phenomenon and methods of assay
Taylor et al. Preservation of normal human plasma in the liquid state. II. Comparative in vitro studies on the physiologic activity of labile constituents of liquid and frozen plasma
EP0259463A4 (en) HEPARIN ANALYSIS.
Hagag et al. Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers Egyptian studies
Meltzer et al. Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives
Simpson Medicolegal alcohol determination: Widmark revisited.
Feinstein et al. The duration of activity in acute rheumatic fever
MIDDLETON et al. Activated coagulation times of whole blood in normal dogs and dogs with coagulopathies